Ronald Allen Louks
Net Worth

Last updated:

What is Ronald Allen Louks net worth?

The estimated net worth of Mr. Ronald Allen Louks is at least $5,005,666 as of 13 Sep 2021. He has earned $442,546 from insider trading and has received compensation worth at least $4,563,120 in NantHealth, Inc..

What is the salary of Ronald Allen Louks?

Mr. Ronald Allen Louks salary is $570,390 per year as Chief Operating Officer in NantHealth, Inc..

How old is Ronald Allen Louks?

Mr. Ronald Allen Louks is 60 years old, born in 1965.

What stocks does Ronald Allen Louks currently own?

As insider, Mr. Ronald Allen Louks owns shares in one company:

Company Title Shares Price per share Total value
NantHealth, Inc. (NH) Chief Operating Officer 225,857 $0 $0

What does NantHealth, Inc. do?

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Ronald Allen Louks insider trading

NantHealth, Inc.

Mr. Ronald Allen Louks has made 21 insider trades between 2017-2021, according to the Form 4 filled with the SEC. Most recently he sold 9,200 units of NH stock worth $18,041 on 13 Sep 2021.

The largest trade he's ever made was exercising 135,196 units of NH stock on 6 Nov 2017. As of 13 Sep 2021 he still owns at least 225,857 units of NH stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 9,200 $1.96 $18,041
Option
Common Stock 9,200 $0.55 $5,060
Option
Stock Option (right to buy) 9,200 $0.55 $5,060
Option
Common Stock 9,200 $1.96 $18,041
Sale
Common Stock 9,200 $0.55 $5,060
Option
Common Stock 7,320 $2.06 $15,043
Sale
Common Stock 7,320 $0.55 $4,026
Sale
Stock Option (right to buy) 7,320 $0.55 $4,026
Option
Stock Option (right to buy) 7,320 $0.55 $4,026
Option
Stock Option (right to buy) 7,320 $0.55 $4,026
Sale
Common Stock 4,700 $2.25 $10,584
Option
Stock Option (right to buy) 4,700 $2.25 $10,584
Option
Common Stock 4,700 $2.25 $10,584
Option
Common Stock 16,613 $2.3 $38,143
Option
Stock Option (right to buy) 16,613 $2.3 $38,143
Sale
Common Stock 16,613 $2.3 $38,143
Option
Stock Option (right to buy) 1,505 $0.55 $828
Option
Common Stock 1,505 $0.55 $828
Sale
Common Stock 1,505 $0.55 $828
Sale
Common Stock 80,000 $3.71 $296,800
Option
Restricted Stock Units 125,195 N/A N/A
Option
Common Stock 125,195 N/A N/A
Option
Restricted Stock Units 125,196 N/A N/A
Option
Common Stock 125,196 N/A N/A
Sale
Common Stock 6,304 N/A N/A
Option
Common Stock 10,000 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Sale
Common Stock 6,305 N/A N/A
Option
Common Stock 10,000 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 6,304 N/A N/A
Sale
Common Stock 5,749 N/A N/A
Option
Common Stock 10,000 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 5,604 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Sale
Common Stock 7,005 $3.41 $23,887
Option
Common Stock 10,000 N/A N/A
Option
Common Stock 125,196 N/A N/A
Option
Restricted Stock Units 125,196 N/A N/A
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 7,005 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Sale
Common Stock 7,095 $3.56 $25,258
Sale
Common Stock 6,475 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 6,175 N/A N/A
Option
Common Stock 10,000 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Sale
Common Stock 5,245 $3.03 $15,892
Option
Restricted Stock Units 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Option
Common Stock 135,196 N/A N/A
Option
Common Stock 135,196 N/A N/A
Option
Restricted Stock Units 135,196 N/A N/A
Sale
Common Stock 6,705 N/A N/A
Option
Restricted Stock Units 40,000 N/A N/A
Option
Common Stock 40,000 N/A N/A
Sale
Common Stock 26,820 N/A N/A

NantHealth key executives

NantHealth, Inc. executives and other stock owners filed with the SEC: